Lam Research Corp
(LRCX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,687,165 | 4,129,067 | 4,915,172 | 3,961,586 | 3,035,887 |
| Marketable Securities | 2,355,067 | 2,528,841 | 1,795,080 | 1,431,550 | 1,647,867 |
| Receivables | 2,900,362 | 2,317,922 | 2,097,099 | 2,191,070 | 2,030,490 |
| Inventories | 2,348,955 | 2,138,050 | 1,900,024 | 1,674,740 | 1,528,620 |
| Other current assets | -2 | -3 | 5 | 0 | 0 |
| TOTAL | $11,467,950 | $11,274,880 | $10,853,540 | $9,408,785 | $8,454,965 |
| Non-Current Assets | |||||
| PPE Net | 1,208,285 | 1,133,529 | 1,071,499 | 1,048,619 | 1,047,254 |
| Intangibles | 1,641,168 | 1,646,343 | 1,652,968 | 1,666,732 | 1,677,940 |
| Other Non-Current Assets | 1,052,969 | 1,002,253 | 981,045 | 814,499 | 733,963 |
| TOTAL | $3,902,422 | $3,782,125 | $3,705,512 | $3,529,850 | $3,459,157 |
| Total Assets | $15,370,370 | $15,057,010 | $14,559,050 | $12,938,630 | $11,914,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 832,847 | 834,138 | 839,877 | 42,407 | 632,292 |
| Accounts payable and accrued liabilities | 722,490 | 662,674 | 592,387 | 498,860 | 452,779 |
| Accrued Expenses | 1,479,242 | 1,333,568 | 1,272,655 | 1,024,793 | 1,114,013 |
| TOTAL | $3,591,053 | $3,406,868 | $3,162,442 | $2,105,661 | $2,565,501 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,992,496 | 4,993,495 | 4,970,848 | 5,043,931 | 3,786,067 |
| Deferred Revenues | 556,474 | 576,488 | 457,523 | 539,601 | 366,417 |
| Other Non-Current Liabilities | 1,278,277 | 1,231,153 | 1,242,268 | 1,239,890 | 1,144,821 |
| TOTAL | $6,270,773 | $6,224,648 | $6,213,116 | $6,283,821 | $4,930,888 |
| Total Liabilities | $9,861,826 | $9,631,516 | $9,375,558 | $8,389,482 | $7,496,389 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,429,083 | 1,440,092 | 1,456,252 | 1,451,622 | 1,455,485 |
| Common Shares | 143 | 145 | 145 | 145 | 142 |
| Retained earnings | 12,839,890 | 12,157,150 | 11,520,590 | 10,991,050 | 10,584,000 |
| Other shareholders' equity | -50,166 | -76,348 | -83,104 | -100,864 | -22,230 |
| TOTAL | $5,508,548 | $5,425,492 | $5,183,489 | $4,549,153 | $4,417,733 |
| Total Liabilities And Equity | $15,370,374 | $15,057,008 | $14,559,047 | $12,938,635 | $11,914,122 |